Repeat plasma screening for the presence or absence of anti-TREK-1 autoantibodies clinical trials

Role of Anti-TREK-1 Autoantibodies in SCVF

This study looks into a serious heart condition called short-coupled ventricular fibrillation (SCVF), which causes sudden cardiac arrest. Researchers are investigating if special substances in the blood, called 'autoantibodies', targetting a heart protein called TREK-1, could be a key factor. The aim is to better understand, diagnose, and predict this condition.